Long-term care is a cross-cutting policy issue that brings together a range of services for persons who are dependent on help with basic activities of daily living. How do governments in OECD countries respond to this growing demand? What has been done to improve access to long-term care, improve quality of services and make care affordable?
This paper provides an inventory of biotechnology data collection in India, including an assessment of how the need for biotechnology-related statistics is being addressed. It also presents an overview of the status of biotechnology in India, with a focus on the agricultural and health sectors.
This framework is intended to provide the basis for statistical compilation work within OECD member countries and those non-member countries wishing to adopt the standards.
This document sets out the provisional, single definition and list-based definitions of biotechnology.
English, , 1,579kb
In 2003 the OECD ran a large-scale survey on molecular genetic testing laboratory practices across 18 OECD countries. The survey was completed October 31, 2003. This report highlights short-term objectives of the survey.
The OECD Study on Private Health Insurance was completed between 2001 and 2004, and assessed the role that private health insurance (PHI) plays in OECD member countries. This page lists all reports released as part of the study.
Statistical work on biotechnology is carried out under the aegis of the OECD Working Party of National Experts on Science and Technology Indicators (NESTI). The above document gives the outcome of the 2004 experts' meeting.
What is the impact of private health insurance on health systems? This report provides the first-ever comparative analysis of the role
This volume contains a selection of the policy studies constituting the OECD Health Project.
Biological resources are the foundation of all biological sciences research. They provide the source material for scientific investigation, leading to many of the discoveries on which biotechnology is founded.